The mechanism and clinical applications of the NMP22 tumor marker immunoassay: a review.
Sawczuk
I S
IS
College of Physicians and Surgeons, Columbia University, Dept. of Urology, New York, NY 10032, USA.
Lee
B
B
D014408:Biomarkers, Tumor / Q000032:analysis*; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis; D005189:False Positive Reactions; D006801:Humans; D007118:Immunoassay / Q000379:methods; D007249:Inflammation / Q000175:diagnosis; D009687:Nuclear Proteins / Q000032:analysis*; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis
D014408:Biomarkers, Tumor; D009687:Nuclear Proteins; C100379:nuclear matrix protein 22